Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
Clinical trial NCT00303329 · COMPLETED
Trial details
- NCT number
- NCT00303329
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2008-10-01
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.